Company Name, Ticker, Suppliers, else..

• Gross Margin

• EBITDA Margin

• Operating Margin

• Pre-Tax Margin

• Effective Tax Rate

• Free Cash Flow Margin

• Cash Flow Margin

Valuation Comparisons

Management Effectiveness

Financial Strength

Dividend Comparisons

Organon and Co (NYSE: OGN)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Organon And Co Profitability Comparisons

Select each Category to receive further Information

Select the Comparisons :

Profitability ▼

Select the Ratio:

None▼

Profitability ▼

None▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OGN Profitability Ratio	Company	Industry	Sector	S&P 500
Gross Profit Margin (Q2 MRQ)	54.36 %	70.91 %	67.38 %	46.15 %
Gross Margin (Q2 TTM)	52.58 %	71.7 %	67.8 %	46.36 %
Gross Profit Margin 5 Yr. Avg.	59.24 %	67.81 %	65.55 %	48.95 %
EBITDA Margin (Q2 MRQ)	16.88 %	21.48 %	18.44 %	20.46 %
EBITDA Margin (Q2 TTM)	19.71 %	25.18 %	20.78 %	20.1 %
EBITDA Margin 5 Yr. Avg.	24.9 %	47.09 %	31.38 %	23.41 %
Operating Margin (Q2 MRQ)	0 %	17.3 %	16.52 %	16.05 %
Operating Margin (Q2 TTM)	7.93 %	20.35 %	17.83 %	16.34 %
Operating Margin 5 Yr. Avg.	23.3 %	15.37 %	14.33 %	19.26 %
Pre-Tax Profit Margin (Q2 MRQ)	11.75 %	13.68 %	10.72 %	13.96 %
Pre-Tax Profit Margin (Q2 TTM)	8 %	16.7 %	12.68 %	13.09 %
Pre-Tax Profit Margin 5 Yr. Avg.	14.52 %	12.98 %	10.37 %	13.52 %
Net Margin (Q2 MRQ)	6.93 %	10.12 %	8.02 %	11.42 %
Net Margin (Q2 TTM)	-0.08 %	13.16 %	9.86 %	10.76 %
Net Margin 5 Yr. Avg.	13.82 %	5.79 %	6.08 %	10.8 %

Business Segment			Profit Margin

Nexplanon Implanon NXT			-
Follistim AQ			-
NuvaRing			-
Ganirelix Acetate Injection			-
Marvelon Mercilon			-
Jada			-
Other Women s Health			-
Renflexis			-
Hadlima			-
Ontruzant			-
Brenzys			-
Other Biosimilars			-
Atozet			-
Zetia			-
Cozaar Hyzaar			-
Vytorin			-
Rosuzet			-
Other Cardiovascular			-
Singulair			-
Nasonex			-
Dulera			-
Clarinex			-
Other Respiratory			-
Arcoxia			-
Fosamax			-
Diprospan			-
Vtama			-
Other Non-Opiod Pain Bone and Dermatology			-
Propecia			-
Emgality			-
Proscar			-
Other			-
U S			-
U S Nexplanon Implanon NXT			-
U S Follistim AQ			-
U S NuvaRing			-
U S Ganirelix Acetate Injection			-
U S Jada			-
U S Other Women s Health			-
U S Renflexis			-
U S Hadlima			-
U S Ontruzant			-
U S Other Biosimilars			-
U S Zetia			-
U S Cozaar Hyzaar			-
U S Vytorin			-
U S Other Cardiovascular			-
U S Singulair			-
U S Dulera			-
U S Clarinex			-
U S Other Respiratory			-
U S Vtama			-
U S Other Non-Opiod Pain Bone and Dermatology			-
U S Propecia			-
U S Other			-
Int l			-
Int l Nexplanon Implanon NXT			-
Int l Follistim AQ			-
Int l NuvaRing			-
Int l Ganirelix Acetate Injection			-
Int l Marvelon Mercilon			-
Int l Other Women s Health			-
Int l Renflexis			-
Int l Hadlima			-
Int l Ontruzant			-
Int l Brenzys			-
Int l Other Biosimilars			-
Int l Atozet			-
Int l Zetia			-
Int l Cozaar Hyzaar			-
Int l Vytorin			-
Int l Rosuzet			-
Int l Other Cardiovascular			-
Int l Singulair			-
Int l Nasonex			-
Int l Dulera			-
Int l Clarinex			-
Int l Other Respiratory			-
Int l Arcoxia			-
Int l Fosamax			-
Int l Diprospan			-
Int l Vtama			-
Int l Other Non-Opiod Pain Bone and Dermatology			-
Int l Propecia			-
Int l Emgality			-
Int l Proscar			-
Int l Other			-
United States			-
Europe and Canada			-
Asia Pacific and Japan			-
China			-
Latin America Middle East Russia and Africa			-

Company's Cashflow Profitability & Other

Profitability Ratios	Company	Industry	Sector	S&P 500
Free Cash Flow Margin (Q2 MRQ)	1.99 %	-0.01 %	0.22 %	1.39 %
Free Cash Flow Margin (Q2 TTM)	13.02 %	17.26 %	13.83 %	9.09 %
Free Cash Flow Margin 5 Yr. Avg.	-	19.28 %	14.86 %	15.58 %
Net Cash Flow Margin (Q2 MRQ)	0 %	0.02 %	-0.02 %	0.13 %
Net Cash Flow Margin (Q2 TTM)	9.27 %	-0.67 %	0.15 %	1.85 %
Net Cash Flow Margin 5 Yr. Avg.	-	4.38 %	3.16 %	6.44 %
Effective Tax Rate (Q2 MRQ)	40.98 %	25.92 %	25.04 %	18.8 %
Effective Tax Rate (Q2 TTM)	57.43 %	21.21 %	23 %	19.44 %
Effective Tax Rate 5 Yr. Avg.	5.37 %	15.08 %	20.51 %	19.76 %

Note
To view Detail Information & Trends click on Individual Category. Example: Y / Y Revenue Change (MRQ) or To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table. Example: Industry Sector S&P 500 For explanation of terms visit: Glossary

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.